SunOpta Announces $51 Million Sale of SunOpta BioProcess Inc.

SunOpta Inc. STKL today announced the sale of SunOpta BioProcess Inc. to Mascoma Corporation. The transaction values SBI at approximately $51 million and will be funded via a combination of preferred and common shares in Mascoma. As a result, the combined company will be approximately 73% owned by existing Mascoma shareholders, approximately 18% by SunOpta, and the balance by other SBI shareholders.